PGEN vs TSM Stock Comparison

TSM currently leads PGEN in this stock comparison, with AIQ scores of 67 vs 55. The clearest difference is risk resilience.

Market data as of Nov 15, 2026 market close· AIQ score gap 12 points
PGEN
Healthcare
vs
TSM
Technology
PGEN
Precigen, Inc.
Price
$4.54
Day move
-2.58%
AIQ Score
55/100
Best edge
Balanced
Sector
Healthcare
TSM
Taiwan Semiconductor Manufacturing Company Limited
Leads
Price
$399
Day move
-1.67%
AIQ Score
67/100
Best edge
Risk Resilience
Sector
Technology

What is the main difference between PGEN and TSM?

TSM leads the current stock comparison as Taiwan Semiconductor Manufacturing Company Limited, with the clearest separation coming from risk resilience and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Precigen, Inc. vs Taiwan Semiconductor Manufacturing Company Limited

Data as of Nov 15, 2026· market close· Cross-sector · Healthcare vs Technology· Coverage 65/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 6/10

TSM leads

TSM leads by 12 AIQ points, primarily on Risk Resilience and Quality. Wall Street currently favors PGEN on target upside.

Competitive: 3 of 6 evidence groups support TSM, and its current signal state is conflicted.

Evidence agreement: 3 of 6Comparison trend: Stable
PGEN

Precigen, Inc.

AIQ Score
55/100
AIQ Edge Score
5/10
TSM

Taiwan Semiconductor Manufacturing Company Limited

Leads
AIQ Score
67/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors TSM over PGEN, 67 versus 55 as of Nov 15, 2026. TSM's advantage is driven primarily by stronger risk resilience and quality. TSM also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors PGEN. 3 of 6 covered evidence groups favor TSM today, and the comparison is rated Competitive on stability: only 3 of 6 covered evidence groups agree. TSM lead: Stable — the AIQ differential has held near 12 points over 30 sessions.

Compare Precigen, Inc. and Taiwan Semiconductor Manufacturing Company Limited across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

PGEN
+21.1%
TSM
+257.5%

Total return comparison

Growth of $10,000, distributions reinvested

PGEN $12,107 · TSM $35,753

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare PGEN and TSM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

PGEN advantage
0
TSM advantage
  • Risk Resilience31 vs 58
    TSM +27
  • Quality60 vs 74
    TSM +14
  • Momentum55 vs 66
    TSM +11
  • Value63 vs 66
    Even

3 of 6 evidence groups favor TSM. TSM’s edge is concentrated in risk resilience and quality.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

PGEN+1 AIQ

No factor moved materially.

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Keltner Channel Breakdown — bearish, volatility, short horizon
TSM0 AIQ

Largest factor move: Momentum +2, not enough on its own to move the overall score.

New signals

  • Price Lost 200-Day MA — bearish, trend, long horizon

TSM's lead narrowed by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — PGEN and TSM both carry a full feed there.

The central trade-off

TSM (Taiwan Semiconductor Manufacturing Company Limited): the stronger current systematic profile, led by risk resilience and quality.

PGEN (Precigen, Inc.): the counter-case, on fundamentals, analyst expectations — but at materially higher volatility, 127% against 61.7%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

TSM

TSM on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

PGEN

PGEN on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

TSM

TSM on the Momentum factor, by 11 points.

Lower downside

TSM

TSM on Risk Resilience, by 27 points.

Analyst upside

PGEN

PGEN on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors TSM, analyst targets favor PGEN. That disagreement is the most useful thing on this page.

MeasurePGENTSMNote
Implied upside to target+164.3%+44.5%PGEN has more room
Target dispersion0%+26.9%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering422Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor TSM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreTSM55 vs 67
FundamentalsPGENon balancerevenue growth 34.9% vs 17.6%; EPS growth 66.7% vs 8%; TTM ROE 42.7% vs 10.9%; gross margin 91% vs 65.8%; operating margin 21.4% vs 57.9% — PGEN takes 4 of 5 decided legs, not all of them
ValuationEvenValue 63 vs 66
TechnicalsTSMPrice vs 50-day -32.6% vs -7.3%; vs 200-day -14% vs -1.1%
Risk ResilienceTSMRisk Resilience 31 vs 58
Analyst expectationsPGENTarget upside 164.3% vs 44.5%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of PGEN and TSM and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 12 points. (supports the conclusion holding)
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on TSM.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

TSM lead: Stable — the AIQ differential has held near 12 points over 30 sessions.

May 27PGEN leads above the line · TSM leads belowNov 13
Today
TSM +12
55 vs 67
7 sessions ago
TSM +6
62 vs 68
30 sessions ago
TSM +11
61 vs 72
90 sessions ago
TSM +10
58 vs 68

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

PGENConflicted

1 bullish / 2 bearish / 2 neutral, conflicted

Only PGEN

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Keltner Channel Breakdown — bearish, volatility, short horizon
TSMConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only TSM

  • Price Lost 200-Day MA — bearish, trend, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon

Both carry 3 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode, Beta Spike Warning.

TSM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

PGENDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -2.58%, AIQ +1 points).

TSMNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.67%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1PGEN closes the Risk Resilience gap — currently 27 points behind, the largest single contributor to TSM's edge.
  2. 2PGEN's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3TSM's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

PGEN leads on balance
MetricPGENTSM
Revenue growth (YoY)34.9%17.6%
EPS growth (YoY)66.7%8%
Gross margin91%65.8%
Operating margin21.4%57.9%
Return on equity (TTM)42.7%10.9%
Debt to equity1.180.14

Performance

TSM leads 5 of 6 windows
MetricPGENTSM
1 week (5 sessions)1.6%6.2%
1 month (20 sessions)-28.9%-3.4%
3 months (63 sessions)-30.7%-7.5%
6 months (126 sessions)2.7%-1.4%
Year to date8.6%31.2%
1 year (252 sessions)12.9%37.2%

Technicals

TSM has the stronger structure
MetricPGENTSM
RSI (14)34.245.3
ADX (14)28.829.2
Price vs 50-day-32.6%-7.3%
Price vs 200-day-14%-1.1%
Volatility (1M, annualized)127%61.7%

Risk

TSM is the more resilient
MetricPGENTSM
Beta1.622.16
Sharpe ratio0.570.95
Sortino ratio0.871.37
Max drawdown-50.7%-27.3%
Current drawdown-47%-17.9%
Annualized volatility85.4%41.8%
Value at risk (95%)-7.2%-4.2%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, PGEN or TSM?

On the Algovestiq AIQ Score, TSM is the stronger of the two as of Nov 15, 2026, scoring 67 against PGEN's 55. The edge comes from risk resilience and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is PGEN or TSM the better buy right now?

TSM carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor TSM over PGEN?

The composite weights Quality, Value, Momentum and Risk Resilience. TSM leads Risk Resilience by 27 points; TSM leads Quality by 14 points; TSM leads Momentum by 11 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, PGEN or TSM?

Analyst price targets imply +164.3% upside for PGEN and +44.5% for TSM, so the Street currently favors PGEN. That points the opposite way to the AIQ Score, which favors TSM. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, PGEN or TSM?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, PGEN or TSM?

PGEN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, PGEN or TSM?

TSM on the Momentum factor, by 11 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, PGEN or TSM?

TSM is the more resilient of the two, so the other name carries the higher downside risk. TSM on Risk Resilience, by 27 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is PGEN more profitable than TSM?

The profitability evidence is mixed: gross margin 91% vs 65.8%; operating margin 21.4% vs 57.9%; ttm roe 42.7% vs 10.9%. PGEN leads on two measures and TSM on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is TSM's lead over PGEN getting stronger or weaker?

TSM lead: Stable — the AIQ differential has held near 12 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the PGEN vs TSM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: PGEN closes the Risk Resilience gap — currently 27 points behind, the largest single contributor to TSM's edge; PGEN's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; TSM's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about PGEN and TSM?

PGEN: 1 bullish / 2 bearish / 2 neutral, conflicted. TSM: 2 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on PGEN is Golden Cross Active (bullish, long horizon). On TSM it is Golden Cross Active (bullish, long horizon).

Compare PGEN and TSM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.